Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Teratoma

2-amino-5-phosphonovalerate has been researched along with Teratoma in 1 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Teratoma: A true neoplasm composed of a number of different types of tissue, none of which is native to the area in which it occurs. It is composed of tissues that are derived from three germinal layers, the endoderm, mesoderm, and ectoderm. They are classified histologically as mature (benign) or immature (malignant). (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1642)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Younkin, DP1
Tang, CM1
Hardy, M1
Reddy, UR1
Shi, QY1
Pleasure, SJ1
Lee, VM1
Pleasure, D1

Other Studies

1 other study available for 2-amino-5-phosphonovalerate and Teratoma

ArticleYear
Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line.
    Proceedings of the National Academy of Sciences of the United States of America, 1993, Mar-15, Volume: 90, Issue:6

    Topics: 2-Amino-5-phosphonovalerate; Amino Acid Sequence; Animals; Base Sequence; DNA, Neoplasm; Glutamates;

1993